ROR1 (39-151, Ig-like Domain), His, Human/Cynomolgus/Rhesus macaque
| $398.00 | |
| Z03939-100 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
IVD Raw Materials
| $398.00 | |
| Z03939-100 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
| Species | Human/Cynomolgus/Rhesus macaque | ||||
| Protein Construction |
|
||||
| Purity | > 95% as determined by Bis-Tris PAGE | ||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||
| Biological Activity | Measured by its binding ability in a functional ELISA.Test result was comparable to standard batch. | ||||
| Expression System | HEK293 | ||||
| Theoretical Molecular Weight | 13.7 kDa | ||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 33-38 kDa based on Bis-Tris PAGE result. | ||||
| Formulation | Lyophilized from a 0.22 μm filtered solution in PBS, pH 7.4 . | ||||
| Reconstitution | It is recommended that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute the lyophilized powder in ddH2O more than 100 μg/ml. | ||||
| Storage & Stability | Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles. |
Immobilized ROR1 (39-151, Ig-like Domain), His, Human/Cynomolgus/Rhesus macaque at 2 μg/ml (100 μl/well) on the plate. Dose response curve for Anti-ROR1 Antibody, hFc Tag with the EC50 of 3.1 ng/ml determined by ELISA. »
The purity of ROR1 (39-151, Ig-like Domain), His, Human/Cynomolgus/Rhesus macaque is greater than 95% as determined by SEC-HPLC. »
ROR1 (39-151, Ig-like Domain), His, Human/Cynomolgus/Rhesus macaque on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
| Synonyms | ROR1; NTRKR1; dJ537F10.6 |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.